appendix j: postmarketing reports - serious hepatic events - Telithromycin - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2006-12-13 08:30:25 Jaundice Liver function tests Hepatitis Bilirubin Acute liver failure Cholecystitis Autoimmune hepatitis Liver Telithromycin Medicine Hepatology Health		appendix j: postmarketing reports - serious hepatic events Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 388,19 KB Share Document on Facebook

	Hepatol Int:453–471 DOIs12072GUIDELINES Acute-on-chronic liver failure: consensus recommendations DocID: 1vpdu - View Document
	A Rational Evidence-based Approach to Abnormal Liver Tests Jane D. Ricaforte-Campos, MD FPCP, FPSG, FPSDE 2013 HSP Post-graduate Course DocID: 1vnki - View Document
	Assessment RunCarcinoembryonic antigen (CEA) Material The slide to be stained for CEA comprised: 1. Appendix, 2. Liver, 3. Colon adenocarcinoma, 4-5. Urothelial carcinoma DocID: 1vhkc - View Document
	Liver cancer patient-derived xenografts to improve disease management in childhood and adolescence: perspectives and challenges of personalized medicine. Stefano Cairo1, Aurore Gorse1, Delphine Nicolle1, Erwan Selingue1, DocID: 1vh8d - View Document
	en13 Leon Bobrowski et al.: Ranked Modeling of Liver Diseases Sequence, enRanked Modeling of Liver Diseases Sequence Leon Bobrowski1,2, Tomasz Łukaszuk1, Hanna Wasyluk3 DocID: 1vebG - View Document